Best Biopharma Outsourcing Companies in Finland
The 33 best Biopharma Outsourcing companies in Finland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Misvik Biology.
- ResearchAndMarkets.com
- market.us
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Finland
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Misvik Biology Provider of precision oncology contract research and toxicology research services | $4M | 44 mo ago | Funding Raised | Juha Rantala Founder & CEO | 2014 | — | — | — |
| 2 | Pharmatory Custom development & manufacturing of human & animal APIs | $3M | 298 mo ago | Seed | Seppo Lankila CEO | 2001 | — | — | — |
| 3 | FinVector Provider of research and development in viral based gene therapies | $2M | 93 mo ago | Funding Raised | — | 1990 | WordPress Block EditorWordPressApple iCloud Mail+19 | — | — |
| 4 | Adamant Health CRO focused on providing bio analytical services | $2M | 52 mo ago | Seed | — | 2017 | Squarespace CommerceCart FunctionalitySquarespace+19 | 8 patents Wearable sensor patches for continuous Parkinson's disease biomarker monitoring | — |
| 5 | Experimentica Developing in vitro, ex vivo and in vivo preclinical ocular models | $1M | 56 mo ago | Funding Raised | Giedrius Kalesnykas Founder & CEO | 2013 | WordPressMySQLPHP+11 | 2 patents Photopharmacology for retinal disease and optical-targeted ocular drug delivery | — |
| 6 | Wipak Provider of packaging and logistic services | $493K | 107 mo ago | Funding Raised | — | 2010 | WordPressApple iCloud MailMicrosoft 365+24 | 5 patents Production of laminated plastic sheets for packaging and sealing applications | — |
| 7 | Anison Therapeutics Provider of HPV associated pharmaceutical products commercialization services | $383K | 55 mo ago | Seed | Senthil Rajendran Co-Founder | 2021 | — | 6 patents Ovatodiolide-based pharmaceutical compositions for therapeutic applications | — |
| 8 | The Solubility Company CRO providing physicochemical measurement services | — | 39 mo ago | Seed | Sami Svanback CEO | 2013 | — | 7 patents Analytical instruments for measuring material dissolution and solubility properties | — |
Top 10 Biopharma Outsourcing companies in Finland
#1
Funding Raised · Turku, Varsinais-suomi · founded 2014$3.6Mraised▾
Provider of precision oncology contract research and toxicology research services. It offers high-throughput cell panel and ex vivo drug screening services integrated with multiomics analyses. It develops diagnostic technology for precision oncology and assessment of targeted therapies for rare cancers by ex vivo testing of therapy efficacy using patient-derived tumor and immune cells. It provides toxicology research services including integrative omics methods for in vitro NanoToxicology, high-throughput organoid screening, big data integration, and predictive ToxicoGenomic testing.
- Mar 2023Grant (prize money)$305.6K
- Feb 2021Grant (prize money)$1.1M
- Jan 2021Grant (prize money)$587K
- Apr 2020Grant (prize money)$424K
#2
Seed · Kuopio, North Savo · founded 2017 · 19 employees$2.3Mraised▾
CRO focused on providing bio analytical services
- Jun 2022Seed$2.3M
- Dec 2020Seed—
#3
Funding Raised · Kuopio, North Savo · founded 2013$1.4Mraised▾
Experimentica offers in vitro, ex vivo and in vivo ocular models. They develop in vitro cell-based models including angiogenesis, cytotoxicity, glaucoma, and others. ExVivo models including corneal permeability and in vivo models such as inflammation, neuroprotection, and others. The company offers services including in vivo imaging, tissue processing, and morphological evaluation, & functional assessment of vision.
- Mar 2022Grant (prize money)$1.1M
- Sep 2019Grant (prize money)$308.6K
#4
Seed · Turku, Varsinais-suomi · founded 2021 · 3 employees$383Kraised▾
Developer of plant-based medication designed to lead the global market in terms of human papillomavirus (HPV) therapy for various skin warts. The company identifies a compound from an ancient medicinal plant that completely eliminates HPV through a molecular mechanism that has received a broad international patent, enabling patients with natural medication that addresses unmet medical needs for HPV-associated genital and common warts, as well as precancerous lesions.
- Mar 2022Conventional Debt$383K
- Nov 2021Seed—
#5
Funding Raised · Kuopio, North Savo · founded 1990 · 201 employees$2.5Mraised▾
FinVector, (originally founded as Ark Therapeutics by Professor Seppo Ylä-Herttuala in the mid-90s) is engaged in the research and development of viral-based gene therapy products. The company has over 20 years of experience in virus development and manufacturing. The company has experience in HEK293, HEK293T, A549, and other cell lines. The company has capabilities to work with a broad range of viral vectors, mainly Adenoviruses (recombinant, oncolytic), Adeno Associated Virus (AAV) and Lentivirus and can develop and manufacture them using either serum-free suspension bioreactor approaches or controlled and disposable fixed bed bioreactor processes. The company's scalable serum-free suspension culture-based manufacturing process platform for adenoviruses (ATOSUS) has been used for clinical supply. The company's services include process development and scale-up, cGMP manufacturing, aseptic filling, stability studies, cell banking and viral seed stocks, assay development and regulatory support. Their GMP facility is approved by EU regulators.
- Jan 2019Grant (prize money)$1.8M
- Jan 2017Grant (prize money)$649.4K
#6
Seed · Oulu, North Ostrobothnia · founded 2001 · 13 employees$3.2Mraised▾
Operator of a custom pharmaceutical synthesis and contract manufacturing company in Finland. The company specializes in custom process research and development, scale-up and cGMP manufacturing of key intermediates and active pharmaceutical ingredients, providing isotope labeled substances, stability testing, impurity profiling and biocatalysis services to pharmaceutical companies.
#7
Funding Raised · Helsinki, Uusimaa · founded 2010 · 500 employees$492.7Kraised▾
Provider of packaging and logistic services
- Nov 2017Grant (prize money)$257.8K
- Jan 2017Grant (prize money)$234.9K
#8
Seed · Helsinki, Uusimaa · founded 2013 · 7 employees—raised▾
CRO providing physicochemical measurement services
- Jul 2023Seed—
#9
Acquired · Tuusula, Uusimaa · founded 1994 · 100 employees—raised▾
Contract manufacturer of food supplements and medical devices
#10
Funding Raised · Kuopio, North Savo · founded 1987 · 6 employees—raised▾
Medfiles is a full-service Contract Research Organization (CRO) offering a range of services to the life sciences industry, including regulatory, clinical, R&D, and laboratory services. With over 35 years of experience, the company provides its clients with expertise in human and veterinary medicine, food, feed, and cosmetics.
Funding & investor landscape
Notable founders
How research on Biotechnology is moving in Finland
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 115 Finland-affiliated papers.
- University of Helsinki28
- University of Turku14
- Helsinki Institute of Physics11
- Helsinki University Hospital11
- Natural Resources Institute Finland11
- Gene3
- Messenger RNA3
- DNA polymerase2
- DNA replication2
- Exon2
- Nutrient4
- Cell3
- Antibody3
- Recombinant DNA3
- Fermentation3
- Production (economics)3
- Gene2
- Functional food2
- Product (mathematics)2
- Sustainability2
Where biotechnology is researched across Finland
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.